THI appoints Sandford Smith MD
This article was originally published in Scrip
Executive Summary
Tullis Health Investors, a family of funds and investments focused in emerging biopharmaceutical, medical device, medical service and other healthcare companies, has appointed Sandford Smith a managing director. Mr Smith has served on THI's advisory board since 2008, and was previously executive vice-president of Genzyme and president of Genzyme's international group.